XML 59 R46.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Earnings Per Share - Schedule of Reconciliation of Numerator and Denominator of Basic and Diluted Earnings per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Numerator:        
Net (loss) income attributable to Surgery Partners, Inc. $ (15.5) $ 18.9 $ (27.9) $ (6.0)
Weighted average common shares outstanding:        
Basic (shares) 126,134 125,718 126,053 125,463
Diluted (shares) [1] 126,134 127,370 126,053 125,463
Net loss per share attributable to common stockholders:        
Basic (in USD per share) $ (0.12) $ 0.15 $ (0.22) $ (0.05)
Diluted (in USD per share) [1] $ (0.12) $ 0.15 $ (0.22) $ (0.05)
Stock options        
Net loss per share attributable to common stockholders:        
Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive (shares) 1,052 0 1,152 1,407
Restricted shares        
Net loss per share attributable to common stockholders:        
Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive (shares) 110 0 154 147
[1] The impact of potentially dilutive securities for the three months ended June 30, 2024 and the six months ended June 30, 2024 and 2023 was not considered because the effect would be anti-dilutive.